Clinical trial
Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset…
NCT00050609 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00050609 |
|---|---|
| Title | Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel Study of IC351 (LY450190) in Patients With Diabetic Gastroparesis |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | ICOS Corporation Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastroparesis |
| Intervention type | Drug |
| Interventions | tadalafil, placebo |
| Enrollment | 2 |
| Start date | Feb 1, 2003 |
| Completion | Sep 1, 2003 |
| First posted | Dec 18, 2002 |
| Last update posted | Nov 20, 2007 |
| Countries | Canada |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: